Source:http://linkedlifedata.com/resource/pubmed/id/11987103
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2002-5-2
|
| pubmed:abstractText |
Thomsen-Friedenreich cryptantigen activation (TCA) exposes neonates with necrotizing enterocolitis NEC to the risk of hemolysis after transfusion of blood products. The authors aimed to determine the prevalence of TCA in neonates with NEC and to correlate TCA with severity of disease and outcome.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1531-5037
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright 2002, Elsevier Science (USA). All rights reserved.
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
37
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
791-3
|
| pubmed:dateRevised |
2007-12-5
|
| pubmed:meshHeading | |
| pubmed:year |
2002
|
| pubmed:articleTitle |
T cryptantigen activation is associated with advanced necrotizing enterocolitis.
|
| pubmed:affiliation |
London, England.
|
| pubmed:publicationType |
Journal Article
|